SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-110701
Filing Date
2016-06-30
Accepted
2016-06-30 09:22:11
Documents
8
Period of Report
2016-06-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v443352_8k.htm 8-K 31019
2 EXHIBIT 1.1 v443352_ex1-1.htm EX-1.1 76262
3 EXHIBIT 4.1 v443352_ex4-1.htm EX-4.1 107352
4 EXHIBIT 5.1 v443352_ex5-1.htm EX-5.1 9368
5 EXHIBIT 10.1 v443352_ex10-1.htm EX-10.1 233396
6 EXHIBIT 99.1 v443352_ex99-1.htm EX-99.1 9390
7 GRAPHIC image_001.jpg GRAPHIC 10115
8 GRAPHIC image_002.jpg GRAPHIC 5583
  Complete submission text file 0001144204-16-110701.txt   489848
Mailing Address 332 EAST SCOTT STREET PORT HUENEME CA 93041
Business Address 332 EAST SCOTT STREET PORT HUENEME CA 93041 (805) 488-2800
Stellar Biotechnologies, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1029
Type: 8-K | Act: 34 | File No.: 001-37619 | Film No.: 161741194
SIC: 2834 Pharmaceutical Preparations